Refissa, a new
topical formulation of Tretinoin, has been approved by the U.S. Food and Drug
Administration (FDA). Refissa is the only 0.05% prescription strength,
fragrance-free, emollient-based Tretinoin Cream specifically indicated for dry skin. This topical Tretinoin
cream helps to reduce fine facial wrinkles, rough skin and irregular
Most dermatologists view topical retinoids as the cornerstone of
treatment for sun damaged skin and acne. Most retinoids, however, are
formulated and indicated exclusively for the treatment of acne.
topical retinoids, Tretinoin is the "Gold Standard" of treatments, and
Refissa, formulated in a moisturizing base, is an ideal option for
mature patients with drier photo damaged skin. Sunscreen should be used in conjunction with retinoid products, including Refissa.
In the interest of fair balance, it should be noted that there are other FDA-approved Tretinoin products on the market, such as Renova and Retin-A. Those products differ in their formulation, indication and price. A 40 gram tube
of Refissa may last 2-3 months, depending on individual usage patterns
and costs on average, less than $2.00 per day.
Refissa, from Spear Dermatology Products, Inc, is available by prescription only. Full prescribing and safety information, as well as patient package insert can be found at www.refissa.com.